Literature DB >> 674812

The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.

J A Rosecrans, W T Chance, R M Spencer.   

Abstract

Rats learned to discriminate cyclazocine (2 mg/kg, i.p.) from saline using a two-lever operant (FR-4) procedure within 10 sessions under each drug condition. The cyclazocine discriminative stimulus (DS) was both dose- and time-related, being antagonized by naloxone at doses approximately 80 times that necessary to block the discriminative stimulus effect of morphine. Cyclazocine also generalized to nalorphine, but not to morphine, pentazocine or LSD. These data suggest that cyclazocine produced DS control of behavior by acting at CNS sites different from those affected by morphine or LSD.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 674812

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  3 in total

1.  Drug discrimination training with a single choice trial per session.

Authors:  A Tomie; E Loukas; I Stafford; L Peoples; G C Wagner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques.

Authors:  A M Young; K R Stephens
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids.

Authors:  J M White; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.